课题基金 / 基金详情

DNA Vaccines

DNA Vaccines
DNA疫苗
批准号:
7338778
负责人:
George N. Pavlakis
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
关键词:

项目摘要

项目成果

George N. Pavlakis的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We optimize DNA vaccine procedures for AIDS and eventually other applications. We used optimization of antigen form, expression and delivery to achieve optimal results. The optimized DNA vectors were shown to provide protection from high viremia in both prophylactic and therapeutic vaccination of rhesus macaques infected by SIV, the most faithful primate model for AIDS. We have used molecular adjuvants to increase immune response to DNA vaccination in collaborative studies. We have shown that IL-12 increased both humoral and cellular immune response to SIV DNA vectors in macaques. We have also shown that the optimized DNA is excellent in priming immune response in DNA prime-virus vector boost. The HIV optimized vectors are in clinical trials. The development of several vector combinations from our lab provides the opportunity for additional clinical applications in AIDS and cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IMMUNOGENICITY & EFFICACY OF DNA VACCINES AGAINST SIV INFECTION
  • 批准号:
    7959065
  • 项目类别:
  • 资助金额:
    $10.99万
  • 财政年份:
    2009
  • 负责人:
    George N. Pavlakis
  • 依托单位:
HIV Molecular Biology and DNA Vaccine Approaches Against
COVID-19 vaccine development
  • 批准号:
    10487068
  • 项目类别:
  • 资助金额:
    $66.18万
  • 财政年份:
    --
  • 负责人:
    George N. Pavlakis
  • 依托单位:
Heterodimeric IL-15 in Cancer Immunotherapy
  • 批准号:
    10262144
  • 项目类别:
  • 资助金额:
    $194.36万
  • 财政年份:
    --
  • 负责人:
    George N. Pavlakis
  • 依托单位:
海外基金